Please login to the form below

Not currently logged in
Email:
Password:

Boehringer & Ashoka focus on communities

Boehringer Ingelheim and Ashoka will launch a three-year global initiative to improve health in communities around the world

Boehringer Ingelheim and Ashoka will launch a three-year global initiative to improve health in communities around the world.

The "Making More Health" project will promote healthy individuals, families and communities by identifying and supporting the most promising solutions to challenging health problems. 

The partnership includes support for a series of programmes aimed at identifying innovative health solutions, including the election of 50 leading social entrepreneurs whose ideas are driving cutting-edge systemic solutions in the field of health. In addition, two web-based competitions will open an invitation to the public to submit new ideas on how to improve health in underserved communities. 

The initiative will also focus on the next generation through a youth venture programme to engage young people in designing health solutions for their communities.

Boehringer Ingelheim will support the initiative by engaging its 42,000 employees worldwide in various capacities to help spread an understanding and appreciation of entrepreneurship and health innovation within their own communities.

Professor Dr Andreas Barner, chairman of the board of managing directors at Boehringer Ingelheim, said: "Making More Health brings together two organisations committed to finding innovative people and ideas to help shape the future of the health sector.

"Through this partnership we will bring forth meaningful and sustainable solutions that can achieve individual and family well-being in communities around the globe," he added.

23rd June 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...
Harness the power of data to map new patient pathways
Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset...
What NORD’s RareInsights® 30-year comparative analysis means to us and our clients at OPEN Health
...

Infographics